abt

As the global financial markets stabilize, the world economy starts recovering and stock markets rally, the pharmaceutical sector, too, is heating up with almost daily deal action. On Wednesday, The Wall Street Journal reported Abbott Laboratories (ABT) has joined the bidding for the pharmaceutical...

Abbott Laboratories (ABT) probably did not want to be the one to break this particular record, but it wasn't up to the big pharmaceutical company. It was up to a jury, and the jury ordered Abbott to pay Johnson & Johnson (JNJ) $1.67 billion for patent infringement of its rheumatoid arthritis...

After another sell-off day, investors are no doubt jittery, but at some point the market will have to find a bottom. In the meantime, many continue to build positions in stocks they deem are cheap, defensive or have the growth potential to come out of the recession strongly. Here are some ideas...